Sunday - February 1, 2026
UTMB, Circio partner to evaluate circVec for infectious diseases treatment
January 07, 2026
GALVESTON, Texas, Jan. 7 -- The University of Texas Medical Branch issued the following news release:

* * *

UTMB, Circio partner to evaluate circVec for infectious diseases treatment

*

The University of Texas Medical Branch will partner with Oslo-based biotechnology company Circio Holding ASA to evaluate the use of Circio's circVec therapy for treatment of infectious diseases.

The unique capacity of the circVec technology to . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products